Clinical trial

Effect of Complementary Intracoronary Streptokinase Administration Immediately…

NCT00302419 · Istanbul University, Other · Completed

Key facts

NCT number NCT00302419
Title Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction
Official title Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction
Lead sponsor Istanbul University, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Acute Myocardial Infarction
Intervention type Drug, Procedure
Interventions intracoronary infusion, primary percutaneous coronary angioplasty
Enrollment 95
Start date Oct 1, 2004
Primary completion Feb 1, 2006
Completion Feb 1, 2008
First posted Mar 14, 2006
Last update posted Aug 1, 2008
Countries Turkey (Türkiye)

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies